Cargando…
Methazolamide Is a New Hepatic Insulin Sensitizer That Lowers Blood Glucose In Vivo
We previously used Gene Expression Signature technology to identify methazolamide (MTZ) and related compounds with insulin sensitizing activity in vitro. The effects of these compounds were investigated in diabetic db/db mice, insulin-resistant diet-induced obese (DIO) mice, and rats with streptozot...
Autores principales: | Konstantopoulos, Nicky, Molero, Juan C., McGee, Sean L., Spolding, Briana, Connor, Tim, de Vries, Melissa, Wanyonyi, Stephen, Fahey, Richard, Morrison, Shona, Swinton, Courtney, Jones, Sharon, Cooper, Adrian, Garcia-Guerra, Lucia, Foletta, Victoria C., Krippner, Guy, Andrikopoulos, Sofianos, Walder, Ken R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402314/ https://www.ncbi.nlm.nih.gov/pubmed/22586591 http://dx.doi.org/10.2337/db11-0578 |
Ejemplares similares
-
Mitochondrial dysfunction has divergent, cell type-dependent effects on insulin action
por: Martin, Sheree D., et al.
Publicado: (2014) -
Treat Ankylosing Spondylitis with Methazolamide
por: Chang, Xiaotian, et al.
Publicado: (2011) -
A Case of Paclitaxel-induced Maculopathy Treated with Methazolamide
por: Koo, Nam Kyun, et al.
Publicado: (2012) -
Acute bilateral angle closure glaucoma induced by methazolamide
por: Aref, Ahmad A, et al.
Publicado: (2013) -
Effects of Psychotropic Drugs on Ribosomal Genes and Protein Synthesis
por: Liu, Zoe S. J., et al.
Publicado: (2022)